🇺🇸 FDA
Patent

US 8323662

Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

granted A61KA61K2039/5256A61K2039/5258

Quick answer

US patent 8323662 (Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein) held by IMMUNE DESIGN CORP. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/5256, A61K2039/5258, A61K39/0011, A61K39/001106